Matching placebo administered orally once daily for 2 months clinical trials

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients Who Have Been Stabilized During Hospitalization for Acute Heart Failure

This study looks at whether a medicine called dapagliflozin, started in hospital, can help patients who have been treated for sudden heart failure. It aims to see if the medicine can prevent future heart problems or hospital stays.